We analyzed the dynamics of the expression of transcription factors, VEGF and its receptor VEGFR2, serine-threonine protein kinase mTOR and activity of proteasome and calpain in patients with metastatic renal cancer during therapy with tyrosine kinase inhibitor Votrient and mTOR blocker Afinitor. The expression of hypoxic nuclear factor HIF-1α in the tumor tissue decreased during therapy with the target preparations. The decrease of VEGF and its receptor VEGFR2 was observed only in patients treated with mTOR inhibitor. The increase in calpain activity in the tumor tissue was observed in both groups. These findings extend our understanding of the mechanism of action of target anticancer preparations as allow considering the studied markers as predictors in choosing optimal therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
L. V. Spirina, I. V. Kondakova, E. A. Usynin, et al., Ross. Onkol. Zh., No. 1, 23-25 (2010).
L. V. Spirina, I. V. Kondakova, E. A. Usynin, and Z. A. Yurmazov, Vestn. Ross. Onkol. Nauch. Centra, 23, No. 1, 27-32 (2012).
S. Ben-Shahar, A. Kolmosh, E. Nadav, et al., J. Biol. Chem., 274, No. 31, 21,963-21,972 (1999).
P. Fergelot, N. Rioux-Leclercq, and J. J. Patard, Prog. Urol., 15, No. 6, 1021-1029 (2005).
D. A. Guertin and D. M. Sabatini, Trends Mol. Med., 11, No. 8, 353-361 (2005).
A. Hoffmann and D. Baltimore, Immunol. Rev., 210, 171-186 (2006).
A. Juvekar, S. Manna, S. Ramaswami, et al., Mol. Cancer Res., 9, No. 2, 183-194 (2011).
S. M. Keefe, K. L. Nathanson, and W. K. Rathmell, Semin. Oncol., 40, No. 4, 421-428 (2013).
V. Kohli, W. Gao, C. A. Camargo Jr, and P. A. Clavien, Proc. Natl Acad. Sci. USA, 94, No. 17, 9354-9359 (1997).
M. Miyazawa, M. Yasuda, M. Fujita, et al., Pathol. Int., 59, No. 1, 19-27 (2009).
X. Na, G. Wu, C. K. Ryan, et al., J. Urol., 170, No. 2, Pt 1, 588-592 (2003).
S. Sandmann, F. Prenzel, L. Shaw, et al., Br. J. Pharmacol., 135, No. 8, 1951-1958 (2002).
W. K. Wu, V. Volta, C. H. Cho, et al., Biochem. Biophys. Res. Commun., 386, No 4, 598-601 (2009).
D. H. Yoon, M. H. Ryu, Y. S. Park, et al., Br. J. Cancer., 106, No. 6, 1039-1044 (2012).
C. X. Yue, J. Ma, H. J. Zhou, et al., Sichuan Da Xue Xue Bao Yi Xue Ban., 42, No. 4, 445-450 (2011).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 160, No. 12, pp. 768-772, December, 2015
Rights and permissions
About this article
Cite this article
Spirina, L.V., Usynin, E.A., Kondakova, I.V. et al. Effect of Target Therapy on the Content of Transcription and Growth Factors, Protein Kinase TOR, and Activity of Intracellular Proteases in Patients with Metastatic Renal Cell Carcinoma. Bull Exp Biol Med 160, 798–801 (2016). https://doi.org/10.1007/s10517-016-3313-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-016-3313-6